Sotnichenko B A, Markelova E V, Salienko S V
Khirurgiia (Mosk). 2005(5):20-2.
Twenty-nine patients with acute destructive pancreatitis received combined therapy including recombinant interleukin-2 (ronkoleukin). Treatment with this interleukin led to a decrease of hypercytokinemia, reduced rate of purulent -- septic complications and surgical operations because of these complications.
29例急性坏死性胰腺炎患者接受了包括重组白细胞介素-2（隆可白细胞介素）在内的联合治疗。使用这种白细胞介素进行治疗可降低高细胞因子血症，减少因这些并发症导致的化脓性-脓毒症并发症发生率及外科手术率。
